Latest Manufacturing News

FOS Capital reported a 12% revenue decline and an EBITDA loss of $0.5 million in FY26, impacted by softer market conditions and project delays. However, a $10 million order book and record $130 million pipeline set the stage for a potential turnaround in FY27.

Black Canyon has launched a 5,000m RC drilling campaign at its Wandanya Project, extending the manganese mineralisation footprint to 3.4km and targeting further iron-rich zones along a 9km trend. The maiden resource estimate remains on track for September 2026.

Camplify Holdings slashed its net loss by 95% in FY26, posting a second-half profit driven by cost cuts and the MyWay Mutual insurance launch, setting a foundation for growth in FY27.

Metallium has resolved a key permitting constraint at its Texas Gator Point campus, enabling chlorinated Flash Joule Heating testing to resume ahead of a major September campaign. The company also marks first revenue from its MXene development program and strengthens engineering leadership.

Bayan Mining has finalised the sale of its Bayan Springs North Project to Sun Silver, securing upfront and contingent payments while retaining a 1% royalty to maintain exposure to future exploration success.

PolyNovo reported a 16.1% rise in FY26 revenue to AUD 150 million, driven by strong global sales and manufacturing expansion, yet net profit fell 44% due to a significant asset write-off from an R&D centre fire and lower tax benefits.

Steel & Tube Holdings reported a 13.9% revenue rise and a 376% jump in normalised EBITDA for FY26, despite a statutory net loss of NZD 61.2 million driven by significant asset impairments and ongoing market challenges.

NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.

Terragen Holdings posted a slight increase in net loss to AUD 3.75 million for FY2026, while advancing key commercial trials and securing a $7 million equity raise to fuel growth.

Embelton Limited has reported a solid 20.4% increase in revenue and a 34.7% jump in profit after tax for FY2026, underpinned by a strategic pivot away from residential construction towards infrastructure and social sectors. The company held its dividend steady amid improving cash flow and reduced borrowings.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.

HighCom Limited’s FY26 results reveal a sharp revenue drop and widening loss driven by a US Government shutdown, but a strengthened leadership team and expanded global sales pipeline set the stage for recovery.